ROSS ERIC KERNS M.D. NPI 1023018728

NPI Information

  • NPI: 1023018728
  • Provider Name: ROSS ERIC KERNS, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 9957 SHERRILL BLVD
    KNOXVILLE, TN
    ZIP 37932
  • Phone: (865) 639-2255

Map and Directions

Get Directions

NPI Details

Ross Eric Kerns, M.D. is a hematology and oncology internal medicine in Knoxville, TN with 42 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ross Eric Kerns, M.D. NPI is 1023018728. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: EAST TENNESSEE STATE UNIVERSITY QUILLEN COLLEGE OF MEDICINE
Graduation Year:1984

The provider's business location address is:

9957 SHERRILL BLVD
KNOXVILLE, TN
ZIP 37932-366
Phone: (865) 639-2255
Fax: (865) 691-7888

The NPI 1023018728 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, rasburicase, 0.5 mg (HCPCS:J2783)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Magnesium level (HCPCS:83735)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Uric acid level, blood (HCPCS:84550)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Red blood count, automated test (HCPCS:85045)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Urinalysis, manual test (HCPCS:81002)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Platelet count, automated test (HCPCS:85049)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 7/26/2005 and was last updated on 4/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD20355TENNESSEEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.